Alerus Financial’s Gilead Sciences GILD Stock Holding History

Alerus Financial’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.16M	Buy	8,331 +8,302	+28,628%	+$1.16M	0.06%	136
2025 Q4	$3.56K	Hold	29	–	–	﹤0.01%	429
2025 Q3	$3.22K	Sell	29 -418	-94%	-$47.5K	﹤0.01%	463
2025 Q2	$49.6K	Buy	+447	New	+$47.6K	﹤0.01%	246
2020 Q2	–	Sell	-9,018	Closed	-$674K	–	162
2020 Q1	$674K	Buy	+9,018	New	+$623K	0.09%	115
2017 Q3	–	Sell	-4,640	Closed	-$328K	–	126
2017 Q2	$328K	Hold	4,640	–	–	0.05%	109
2017 Q1	$315K	Hold	4,640	–	–	0.05%	110
2016 Q4	$332K	Hold	4,640	–	–	0.05%	107
2016 Q3	$367K	Hold	4,640	–	–	0.06%	108
2016 Q2	$387K	Buy	+4,640	New	+$412K	0.06%	106

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Alerus Financial's GILD Position: Q1 2026 in Review

Alerus Financial increased its Gilead Sciences (GILD) stake by 28,628% in Q1 2026, buying an estimated $1.16M and bringing the position to 8,331 shares worth $1.16M. The position accounts for 0.06% of the portfolio, ranked #136.

Alerus Financial first reported a position in GILD in Q2 2016 and has held it in 10 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Alerus Financial held 8,331 shares of Gilead Sciences worth $1.16M as of Q1 2026.
Alerus Financial bought 8,302 Gilead Sciences shares in Q1 2026, an estimated $1.16M.
Gilead Sciences made up 0.06% of Alerus Financial's portfolio in Q1 2026, its #136 holding.
Alerus Financial first reported a position in Gilead Sciences in Q2 2016 and has held it in 10 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Alerus Financial's 13F filing for Q1 2026, filed 12 May 2026.